Vinge advises Procuritas Capital Investor VII (“Procuritas”) in connection with its acquisition of PropTech Sweden AB (“PropTech Sweden”) and its subsidiaries Axcell Fastighetspartner AB (“Axcell Fastighetspartner AB”) and Ömangruppen Svenska AB (“Ömangruppen”).

PropTech Sweden is the parent company of Ömangruppen and Axcell Fastighetspartner, two leading companies in indoor climate, energy efficiency, and property management. With over 300 employees and 30 local offices in southern Sweden, Luleå and Örnsköldsvik, the group acts as a close partner to property owners who want to increase energy efficiency or optimize the operation of their property in other ways. Procuritas has since its founding in 1986 completed more than 50 investments and hundreds of add-on acquisitions in the Nordic region. As real estate accounts for 40% of Sweden's total energy consumption, Procuritas considers PropTech Sweden a vital player in the climate transition, especially in view of upcoming EU regulations on reduced emissions. Completion of the acquisition is subject to customary competition clearance.

Vinge’s team mainly consisted of Jonas JohanssonMaria Dahlin Kolvik, Clara Sohlberg, Eskil Nyström (M&A), Karl-Gustaw Tobola (Banking and Finance), Daniel Prawitz, Mario Saad, Clara Klingspor (Corporate Commercial), Julia Löfqvist (Compliance), Petronella Hallberg, Amelia Rihs (Employment) Lina Österberg (Environment), Mathilda Persson, Alva Skott (IT & GDPR), Alexandra Tamm (Real Estate), Kristoffer Sällfors (Public Procurement) and Johan Walhbom (EU, Competition and Regulatory).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025